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Abstract 
 
Introduction: Theoretical models and empirical research support the role of negative 
affect in bulimia nervosa (BN). However, treatments that target negative affect in BN have not 
outperformed traditional, eating-disorder-focused treatments for BN. An alternative mechanism 
of BN is dysfunctional positive affect (i.e., reward processing). The present study aimed to 
understand associations among dysfunctional reward processing, affect, and eating-disorder 
symptom expression by testing an interactive model of reward-based processes (reward learning, 
effort valuation, delay discounting, inhibitory control) in women with BN. Method: Participants 
were community-recruited medication-free adult women aged 18-30 with BN (n=20) or healthy 
controls (HCs; n=20). Behavioral tasks and self-report measures were used to assess reward 
learning, effort valuation, delay discounting, inhibitory control, BN symptom frequencies, and 
affect. Results: Women with BN did not differ from HCs on effort valuation and inhibitory 
control; however, women with BN showed less delay discounting and demonstrated slower 
reward learning compared to HCs. Frequency of fasting and excessive exercise episodes 
increased as inhibitory control decreased. Slowed reward learning was associated with increased 
self-induced vomiting frequencies in BN. Conclusions: Results suggested a modified model of 
reward dysfunction in BN, with delay discounting, reward learning, and negative urgency as 
central features. Given the associations of reward learning, delay discounting, and negative 
urgency, clinicians working with persons with BN may introduce strategies, such as pleasant 
activity scheduling, as a means to promote positive affect, regulate negative affect, and 
potentially decrease symptom expression in BN. (Word Count: 238 words) 
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Reward Processing and Inhibitory Control in Women with Bulimia Nervosa 
 
Bulimia nervosa (BN) is an eating disorder characterized by recurrent binge eating, 
inappropriate compensatory behaviors, and overvaluation of body weight and/or shape in persons 
without an objectively low body weight (American Psychiatric Association, 2013). Binge eating 
is defined as eating a large amount of food in a distinct time period (e.g., two hours) and 
experiencing a subjective loss-of-control over eating. Inappropriate compensatory behaviors are 
behaviors used to counteract the effects of binge eating, influence body shape and/or weight, 
and/or gain a sense of control over eating. Inappropriate compensatory behaviors include fasting, 
severe food restriction, excessive exercise, self-induced vomiting, misuse of laxatives, diuretics, 
enemas, and/or syrup of ipecac, and insulin omission among persons with insulin-dependent 
diabetes.  
BN is a public health priority. BN affects approximately 1-3% of people in their lifetime 
(Smink, van Hoeken, & Hoek, 2013; Stice, Marti, & Rohde, 2013; Trace et al., 2012). According 
to the US Burden of Disease Collaborators, the number of years lived with an eating disorder 
increased by 55.4% and disability-adjusted life years lost due to an eating disorder increased by 
60.9% from 1990 to 2010 (Murray et al., 2013). Moreover, eating disorders rank as the 12th 
leading cause of death and disability among young women aged 15 to 19 in high-income 
countries and rank as the 16th leading cause of death and disability among women of all ages 
(Erskine, Whiteford, & Pike, 2016).  
Despite the considerable burden-of-disease associated with BN, the best-available 
evidence-based psychotherapies for BN do not work for 40-60% of patients (Keel & Brown, 
2010; Steinhausen & Weber, 2009). Moreover, pharmacologic treatments (namely 
antidepressants) have modest efficacy; although BN symptom frequencies reduce by 
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approximately 50% at short-term follow-up (eight weeks), symptom reduction is negligible at 
long-term (one year) follow-up (Hay & Claudino, 2012). Low efficacy of current treatments for 
BN suggest that core mechanisms of BN are not being fully treated with currently available 
interventions. Thus, additional research to elucidate maintaining mechanisms of BN is critically 
needed so that more effective treatments can be developed. 
Negative Affect in Bulimia Nervosa 
Scholars in the field of BN have provided substantial theoretical and empirical support 
for negative affect as a core mechanism of BN (for a review see (Stice, 2016)). An important 
theoretical model of negative affect in BN is the Affect-Regulation Model (Polivy & Herman, 
1993), which posits that negative emotions trigger binge eating and inappropriate compensatory 
behaviors which, in turn, provide temporary relief from aversive emotions and cognitions. Thus, 
the Affect-Regulation Model indicates that, over time, eating-disorder behaviors increase 
because they are negatively reinforcing (i.e., provide temporary relief from aversive emotions). 
Behaviorally and biologically based empirical research has supported the Affect-Regulation 
Model and suggested that negative affect plays an important role in the etiology, maintenance, 
and prognosis of BN (e.g., (Haedt-Matt & Keel, 2011; Stice, 2016; Stice & Fairburn, 2003)). A 
recent systematic review of prospective risk factors for the development of BN found that pre-
morbid negative affect predicts the onset of BN, indicating that negative affect is an important 
etiological factor for BN (Stice, 2016). Other behavioral (i.e., non-biological) research has 
demonstrated a temporal association among negative affective states and BN symptoms through 
ecological momentary assessment (EMA), an assessment tool that enables real-time tracking of 
affective states, BN symptoms, and the temporal association of these symptoms in a person’s 
natural environment. EMA research has shown that high levels of negative affect and stress are 
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significant antecedents of binge eating and inappropriate compensatory behaviors episodes in 
BN (Haedt-Matt & Keel, 2011; Lavender et al., 2016; Smyth et al., 2007). Although some EMA 
studies found that binge eating was prospectively associated with decreased negative affect in 
BN (Berg et al., 2013; Lavender et al., 2016; Smyth et al., 2007), meta-analytic results suggested 
that binge eating is prospectively associated with increased negative affect in BN (Haedt-Matt & 
Keel, 2011). Researchers have posited that heterogeneity of post-binge-eating affect in BN may 
be due to differences in statistical analysis methods (Engel et al., 2013).  Engel et al. (2013) 
noted that results from EMA studies may differ because some researchers have used linear mixed 
models to assess immediately before and after binge eating, whereas other researchers have used 
growth curve models to examine the general trajectory of affect pre- and post-binge eating. 
Results from previous studies indicated that purging behaviors (e.g., self-induced vomiting) are 
prospectively associated with decreased negative affect (Berg et al., 2013; Haedt-Matt & Keel, 
2011). Other researchers have shown that negative urgency, or the tendency to act rashly when 
experiencing negative affect, is significantly associated with BN psychopathology. Meta-analytic 
results suggested a medium-sized association among negative urgency and BN symptoms 
(r=0.40) (Fischer, Smith, & Cyders, 2008).  
Finally, in addition to negative affective states, preliminary evidence suggested that 
affective lability may be an important contributor to BN psychopathology. A recent study 
examined affective instability and degree of affective change (vs. level of negative affect) using 
EMA in women with BN; results suggested that extreme increases in negative affect occurred 
prior to binge-eating and purging episodes, and extreme increases in positive affect occurred 
after binge-eating and purging episodes (Berner et al., 2017). Thus, previous behavioral research 
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supports the Affect-Regulation Model of BN and indicates that negative affect is a reliable 
prospective predictor of BN symptoms. 
Incorporating negative affect into eating-disorder nosology also has diagnostic utility. For 
example, using latent class modeling, scholars have reliably classified persons with BN into 
subtypes based dietary restriction and high (vs. low) levels of negative affect (Chen & Le 
Grange, 2007; Grilo, Masheb, & Berman, 2001; Stice & Agras, 1999; Stice et al., 2001; Stice, 
Bohon, Marti, & Fischer, 2008; Stice & Fairburn, 2003). Persons with BN who reported high 
levels of both negative affect and dietary restriction (a “dietary-negative” subtype of BN) 
reported more frequent binge eating and inappropriate compensatory behaviors, increased 
psychosocial impairment, and had greater rates of treatment non-response than persons with BN 
who reported elevated levels of dietary restraint only (Stice et al., 2008; Stice & Fairburn, 2003). 
These findings suggest that high levels of negative affect are associated with increased illness 
severity and poorer prognosis of BN. 
Biological research on negative affect in BN dovetails with the previously described 
behavioral research. Dysfunction in the serotonergic (5-HT) system – a system implicated in 
mood, eating, sleep, and impulse control – has been observed in adults with BN. Scholars have 
theorized that binge-eating episodes lead to increases in 5-HT in the brain that, in turn, decrease 
5-HT receptor sensitivity in persons with BN (Jimerson, Lesem, Kaye, & Brewerton, 1992). 
Research has shown that persons with BN have decreased 5-HT receptor binding (Kaye et al., 
2001; Marazziti, Macchi, Rotondo, Placidi, & Cassano, 1988) and increased 5-HT reuptake 
(Goldbloom, Hicks, & Garfinkel, 1990), suggesting that too little 5-HT is available for binding at 
5-HT receptors. Based on this evidence, selective-serotonin reuptake inhibitors designed to 
increase 5-HT availability have been used as a pharmacological intervention for BN (Goldstein, 
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Wilson, Ascroft, & al-Banna, 1999; Levine, 1992). Considered together, biological research 
suggested that there is dysfunction of the 5-HT system in BN and, given the associations of the 
5-HT system with mood, further underscores the role of negative affect in BN psychopathology. 
Due to the clear importance of negative affect in BN, psychological and pharmacological 
treatments that directly target high negative affect in BN were developed. One of the most 
popular traditional psychotherapies for BN is cognitive-behavioral therapy (CBT) (Fairburn, 
1981), which initially focused almost exclusively on eating-disorder-specific behaviors and not 
on negative affect. Given that remission rates of BN in CBT treatment studies were low and 
meta-analytic results showed that approximately 40-60% of patients with BN did not achieve 
symptom remission (Thompson‐Brenner, Glass, & Westen, 2003), researchers developed 
Enhanced Cognitive Behavioral Therapy (CBT-E) for the trans-diagnostic treatment of eating 
disorders (Fairburn, 2008). CBT-E focuses on establishing regular patterns of eating and self-
monitoring – which includes completing daily logs of regular eating, loss-of-control eating, and 
inappropriate compensatory behaviors, and tracking emotions and cognitions accompanying 
eating behaviors – to help clients identify factors contributing to disordered-eating behaviors and 
cognitions. Two varieties of CBT-E exist: (1) a focused version (CBT-Ef) that solely targets 
eating-disorder symptoms; and (2) a broad version (CBT-Eb) that targets eating-disorder 
symptoms and incorporates additional, optional modules to address issues common in eating 
disorders, including mood “intolerance” (negative affect and mood-related cognitive distortions) 
and interpersonal difficulties. Initial evidence suggested that persons with more “complex” 
eating-disorder cases (e.g., more co-morbid psychopathology) had greater eating-disorder 
symptom reductions when treated with CBT-Eb versus CBT-Ef at end-of-treatment and 60-week 
follow-up (Fairburn et al., 2009), suggesting that directly targeting the negative-affect system is 
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important for improving treatment outcome results in BN. A recent randomized-control trial 
showed that persons with BN and co-morbid borderline personality disorder – a psychiatric 
disorder characterized by marked affective instability and high levels of negative affect – show 
similar remission rates with CBT-Eb (vs. CBT-Ef) at end-of-treatment, with 40.0% and 44.0% 
achieving remission at end-of-treatment for CBT-Eb and CBT-Ef, respectively (Thompson-
Brenner et al., 2016). However, persons who received CBT-Eb fared better at six-month follow-
up, with 46.7% in the CBT-Eb group achieving full BN remission versus 36.8% in the CBT-Ef 
group. It is noteworthy that remission rates remained below 50% for both forms of CBT-E. Thus, 
while targeting negative affect in BN through CBT-E has shown some promise for increasing 
treatment efficacy, less than 50% of those with BN who receive CBT-E achieve symptom 
remission. 
Other evidence-based therapies that specifically target negative affect in BN have been 
developed. Dialectical Behavior Therapy (DBT), a therapy that was initially developed for 
chronic suicidality and borderline personality disorder that focuses on reducing affective 
instability and negative affect, was modified for use in patients with BN due to the clear role of 
negative affect on bulimic-symptom expression (Safer, Telch, & Chen, 2009). An initial 
randomized-control trial showed that persons with BN who received DBT had a 28.6% remission 
rate versus 0% of participants in the waitlist-control group after 20 weeks (Safer, Telch, & 
Agras, 2001). A recent study compared DBT vs. CBT-E in persons with BN who had poor initial 
treatment response to a guided self-help version of CBT (<65% remission of disordered-eating 
behaviors) (Chen et al., 2017). Results showed that DBT and CBT-E led to similar reductions of 
binge-eating frequency at end-of-treatment, 6-months follow-up, and one-year follow-up. 
However, persons with BN who received DBT (vs. CBT-E) showed greater reductions in self-
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induced vomiting (Chen et al., 2017). Another more recently developed therapy is Integrative 
Cognitive-Affective Therapy (ICAT) (Wonderlich, Peterson, & Smith, 2015), which focuses on 
helping clients recognize temporal associations among (negative) affective states and bulimic 
symptoms. A randomized-control trial of ICAT versus CBT-E in persons with BN showed that 
ICAT did not outperform CBT-E, and both therapies facilitated similar reductions in binge-
eating and purging frequencies (Wonderlich et al., 2014). Thus, despite the important role that 
negative affect plays in the etiology and maintenance of eating disorders, results from the 
psychological treatment literature show that, in general, targeting negative-affective processes 
does not improve results of traditional eating-disorder-focused treatment for BN. 
Pharmacological treatments that solely target negative affect systems in BN, such as 
selective-serotonin reuptake inhibitors, do not fare better than psychotherapies in treating BN. 
Pharmacological treatments have modest outcomes at short term follow-up, with patients 
experiencing only 50% decrease in binge-eating and purging frequencies at the end of 
randomized-control trials, and negligible outcomes at long-term (one year) follow-up (Hay & 
Claudino, 2012). Approximately 30-45% of patients with BN who experienced symptom 
reduction when taking a selective-serotonin reuptake inhibitor experienced symptom relapse over 
four- to six-month medication maintenance phases (Bacaltchuk & Hay, 2003; Hay & Claudino, 
2012; Mitchell, Roerig, & Steffen, 2013). Additionally, drop-out rates for pharmacologic 
treatments of BN were approximately 40%, likely due to low tolerability of side effects (Hay & 
Claudino, 2012).  
In summary, research suggests that psychological and pharmacological treatments that 
exclusively target negative affect in BN do not show improvements over traditional eating-
disorder psychotherapies, suggesting that while negative affect is an important mechanism of 
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BN, it is not sufficient in our current understanding of BN. Thus, the identification of 
mechanisms that move beyond a focus on negative affect is imperative for developing a more 
comprehensive understanding of factors that maintain BN and can serve as future treatment 
targets. 
Application of a Trans-Diagnostic Model of Imbalanced Reward Processing and Inhibitory 
Control to Bulimia Nervosa 
One potential mechanism of BN that is not the focus of currently available treatments for 
eating disorders is positive affect (e.g., the reward-processing system), which is responsible for 
the experience of pleasurable emotions and responses to rewarding stimuli, such as palatable 
food. Many psychiatric disorders that frequently co-occur with BN are characterized by 
dysfunctional or low positive affect. For example, results from a nationally representative sample 
of persons with eating disorders suggested that the lifetime co-morbidity rate of BN and major 
depressive disorder is approximately 50.1% (Hudson, Hiripi, Pope, & Kessler, 2007), and a 
defining feature of major depressive disorder is low positive affect (e.g., anhedonia) (American 
Psychiatric Association, 2013). Substance use disorders also co-occur with BN, with lifetime co-
morbidity estimates from a nationally-representative sample suggesting that up to 36.8% of 
persons with BN also have had a drug or alcohol use disorder (Hudson et al., 2007). In addition, 
results from a literature review (O'Brien & Vincent, 2003) and a meta-analysis (Calero‐Elvira et 
al., 2009) of co-morbid conditions in treatment-seeking persons with BN suggested higher rates 
of substance use disorders in BN compared with the general population and other eating 
disorders (e.g., binge-eating disorder or anorexia nervosa). Biological research has shown robust 
dysfunction in the positive-affect (reward-processing) and inhibitory control systems in persons 
with substance abuse disorders, which has been summarized into a model of reward processing 
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and inhibitory control involved in addictions (Volkow, Fowler, Wang, Baler, & Telang, 2009) 
(see Figure 1).  
Volkow’s model contends that consummatory behavior is regulated by three distinct 
reward-based processes (delay discounting, effort valuation, reward learning) and inhibitory 
control, and that imbalances among these processes maintain symptom expression in persons 
with substance use disorders. Specifically, Volkow posits that desire to obtain a substance now 
versus later (delay discounting), great effort to obtain and consume a substance (effort 
valuation), and difficulty learning stimulus-reward associations between using the substance and 
consequences of using the substance (reward learning) override and weaken inhibitory control. 
Weakened inhibitory control is theorized to result in impulsive consumption of a substance. 
Although Volkow’s model was developed for understanding factors that maintain substance 
misuse, it is relevant to understanding bulimic behaviors. For example, research has 
demonstrated that persons with BN show a preference for obtaining a reward now versus later 
(delay discounting) (Kekic et al., 2016) and increased efforts to work for and obtain food (effort 
valuation) (Bodell & Keel, 2015; Schebendach, Broft, Foltin, & Walsh, 2013). Moreover, 
persons with BN appear to have reduced reward learning, as evidenced by recurrent engagement 
in binge eating and compensatory behaviors despite physical consequences and psychosocial 
impairment (Labouliere, Terranova, Steinglass, & Marsh, 2016). Dysregulated reward-based 
processes in BN may work in concert to decrease inhibitory control over food intake, resulting in 
over-consumption of food accompanied by loss-of-control (i.e., binge eating).  
Biological research has implicated alterations in reward-processing, as demonstrated by 
alternations in the dopaminergic system, in the maintenance of substance use disorder 
psychopathology. Reward-processing alterations have been characterized as decreased striatal 
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dopamine (DA) D2 receptor availability (Volkow et al., 2009) and blunted striatal DA release to 
rewarding stimuli (e.g., drugs, alcohol) (Martinez et al., 2005; Martinez et al., 2007). Inhibitory 
control deficits in substance use disorders include reduced availability of striatal DA D2, which is 
associated with decreased activity in brain regions implicated in inhibitory control, including the 
orbitofrontal cortex, cingulate gyrus, and prefrontal cortex (Volkow et al., 2001; Volkow et al., 
1993; Volkow et al., 2007). Thus, Volkow purports that decreased availability of DA D2 
receptors overrides fronto-striatal circuits associated with inhibitory control, thereby decreasing 
ability to inhibit reward-driven behaviors. In sum, Volkow’s model has been supported by 
neurobiological research on reward processing and inhibitory control.  
There are clear and compelling parallels between substance use disorders and BN that 
warrant the application of Volkow’s model to BN psychopathology. First, persons with 
substance use disorders use drugs and/or alcohol as a means to temporarily regulate their 
(negative) affect in the same way that persons with BN use binge eating and inappropriate 
compensatory behaviors to regulate their negative emotions (Gold, Frost-Pineda, & Jacobs, 
2003). Second, persons with BN and persons with substance use disorders both report subjective 
loss-of-control over disorder-specific behaviors (e.g., subjective feelings that they cannot stop or 
cut down on what or how much they are eating or drinking) and continue to engage in disorder-
specific behaviors despite potential negative consequences (Gold et al., 2003). Finally, lifetime 
co-morbidity estimates from a nationally representative sample indicated that 36.8% of persons 
with BN have had a substance use disorder (Hudson et al., 2007). Given the parallels between 
and co-morbidity of BN and substance use disorders, examination of the reward-processing 
system, inhibitory control system, and the interaction of these systems in BN could lead to better 
understanding of mechanisms that underlie BN and thereby advance treatments for BN. 
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Reward-Processing Dysfunction in Bulimia Nervosa 
Emerging research supports reward-processing dysfunction as a candidate disease-
mechanism of BN. Candidate disease-mechanisms refer to processes that have shown 
preliminary evidence for maintaining disease symptom expression. Neurobiological and 
behavioral data implicate the dopaminergic (DA) system in ingestive behavior (Small, Jones-
Gotman, & Dagher, 2003; Volkow et al., 2002) and, as with substance use disorders, reduced 
striatal DA levels and DA D2 receptor availability – biological markers of reward-processing 
dysfunction – have been observed in BN. Pre-clinical studies of bulimic-type behaviors in 
rodents found that binge-like consumption of palatable food (e.g., sucrose solutions) was 
associated with decreased striatal DA release in the nucleus accumbens (Rada, Avena, & 
Hoebel, 2005) and decreased striatal D2 receptor availability (Bello, Lucas, & Hajnal, 2002; 
Johnson & Kenny, 2010). Early clinical work in persons with BN showed lower levels of 
cerebrospinal fluid homovanillic acid (HVA; a DA metabolite) compared to healthy controls 
(Jimerson et al., 1992; Kaye et al., 1990). Moreover, these studies found that lower levels of 
HVA correlated with increased frequency of binge-eating episodes in persons with BN.  
Neuroimaging findings in persons with BN converge with early pre-clinical and clinical 
work. Broft et al. (2012) used positron emission tomography (PET) imaging to examine striatal 
response to a psychostimulant in persons with BN and found significantly blunted striatal DA 
response to a psychostimulant in the posterior and anterior putamen of persons with BN 
compared to healthy controls. Blunted striatal DA response was correlated with increased binge-
eating and self-induced vomiting frequencies and increased caloric density of binge-eating 
episodes. Another study found decreased striatal DA transporter availability in persons with BN 
compared to healthy controls using single photon emission computed tomography (SPECT) 
 
12 
 
(Tauscher et al., 2001). Finally, research using functional magnetic resonance imaging (fMRI) 
found that persons recovered from BN do not have differential reactions to wins and losses like 
healthy controls, as evidenced by significantly lower activation of the left caudate nucleus and 
right anterior ventral striatum during a guessing game paradigm in which participants could win 
or lose money based on their guess (Wagner et al., 2010). 
In addition to neurobiological work, behavioral evidence points to dysfunctional reward 
processing in BN. Persons with BN showed greater effort valuation compared to healthy controls 
by working harder for food reward on the Progressive Ratio Task (Bodell & Keel, 2015; 
Schebendach et al., 2013). Persons with BN also showed greater delay discounting than healthy 
controls because they discounted the value of a monetary reward as a function of its delay during 
a delay discounting task (Kekic et al., 2016). In pre-clinical rodent models, increased delay 
discounting, as measured by a delay discounting task developed for rodents, was associated with 
increased binge-eating frequency (Cano, Murphy, & Lupfer, 2016). Other behavioral research 
suggests persons with both acute and remitted BN show difficulties with reward learning, which 
is conceptualized as the ability to learn stimulus-response associations and subsequently 
modulate behavior to optimize chance of reward receipt (e.g., positive feedback, money, 
palatable food). One study found that persons with BN showed deficits on a probabilistic 
learning task that provided positive (smiling face) and negative feedback (frowning face) to 
participant responses (Labouliere et al., 2016). Specifically, persons with BN were not able to 
modulate behavior from feedback to improve response accuracy like healthy controls, and 
increased inaccuracy of responses was associated with increased binge-eating and self-induced 
vomiting frequency in persons with BN. Moreover, catecholamine-depleted (Grob et al., 2012) 
and non-catecholamine-depleted (Wagner et al., 2010) persons with recovered BN did not 
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distinguish between positive and negative feedback on reward-based tasks compared to healthy 
controls, suggesting decreased ability to form stimulus-reward associations and impaired reward 
learning. Studying catecholamine depletion in remitted BN is important because catecholamines 
are a parent class of neurotransmitters that include DA and are implicated in the functioning of 
the reward-processing system (Kaye, 2008). Catecholamine depletion results in decreased levels 
of DA in the central nervous system and is thought to temporarily induce lower DA levels 
similar to those present in persons with active BN. 
Thus, across multiple samples and methods, the extant research literature suggests that 
there are broad deficits in reward-processing in BN and that reward dysfunction is associated 
with increased frequency of binge eating and purging episodes. The association of reward-
processing dysfunction with increased frequency of bulimic symptoms is important because it 
suggests that targeting the mechanisms underlying impaired reward processing may decrease 
bulimic-symptom frequency. 
Inhibitory Control Deficits in Bulimia Nervosa 
In addition to deficits in reward processing, inhibitory control deficits are well-
documented in persons with BN and represent a defining feature of BN. For example, the DSM-5 
diagnostic criteria for BN require that persons experience loss-of-control during eating episodes, 
and loss-of-control during binge eating could also be conceptualized as decreased inhibitory 
control. Empirical research supports this diagnostic criterion. For example, meta-analytic results 
of behavioral research suggested that persons with BN show decreased behavioral inhibitory 
control toward both non-disease-related (e.g., monetary) and disease-related (e.g., food, body) 
stimuli that they are instructed to ignore (Wu, Hartmann, Skunde, Herzog, & Friederich, 2013). 
Other behavioral research has shown that persons with BN exhibit difficulty in ceasing impulsive 
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behavior once it is already underway (e.g., feeling like one cannot stop eating a bag of chips after 
starting) compared to healthy controls (Wu, Giel, et al., 2013). Thus, behavioral research 
suggested that persons with BN have difficulties inhibiting responses to initial presentation of a 
rewarding stimuli as well as difficulty ceasing impulsive behavior that is already underway. 
Neuroimaging evidence converges with behavioral evidence to support dysfunctional 
inhibitory control in persons with BN. fMRI studies of adolescents (Marsh et al., 2011) and 
adults (Marsh et al., 2009; Skunde et al., 2016) with BN showed decreased behavioral inhibitory 
control and decreased activation of fronto-striatal circuits when asked to withhold responses to 
both non-disease-related (e.g., neutral arrows) and disease-related (e.g., body, food) stimuli. 
Additionally, these studies found that binge-eating (Marsh et al., 2011; Marsh et al., 2009; 
Skunde et al., 2016) and self-induced vomiting (Marsh et al., 2011) frequency increased with 
decreased activation of fronto-striatal circuits. A recent cross-sectional fMRI study showed that 
persons with BN do not show expected maturation of circuits associated with inhibitory control 
over time compared to healthy controls (Dreyfuss et al., 2017). The finding that inhibitory 
control functioning was deficient in both adolescents and adults with BN is important because it 
is widely documented that fronto-striatal circuit functioning, and therefore inhibitory control, 
improves with age; thus, poor inhibitory control may be an important neurocognitive marker of 
BN. Other research used electroencephalogram (EEG) event-related potentials (ERP) and 
showed that women with BN showed reduced amplitude and shorter latency of N200 waveforms 
and greater amplitude of P300 waveforms during an oddball distractor task, suggesting decreased 
inhibitory control (Merlotti et al., 2013). In sum, previous evidence from behavioral and multi-
modal neuroimaging studies suggested that persons with BN exhibit decreased inhibitory control, 
which may explain why they experience subjective loss-of-control during binge-eating episodes.  
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Clinical Implications 
Treatment research for substance use disorders has been guided by Volkow’s model, 
leading to the development of novel treatments for substance use disorders. These novel 
treatments simultaneously target dysfunctional reward-processing and inhibitory control systems 
by decreasing limbic system (e.g., reward processing) activation and increasing inhibitory 
control activation (Cabrera et al., 2016) in response to disease-salient cues (e.g., drugs, alcohol). 
Such treatments include novel applications of pharmacological agents, such as modafinil and 
aripiprazole (Abilify ). Modafinil is a mild stimulant indicated for use in decreasing daytime 
sleepiness in persons with narcolepsy through modulation of the dopaminergic system. Because 
modafinil modulates dopaminergic system functioning and dopaminergic dysfunction has been 
observed in persons with substance use disorders, researchers tested the effects of modafinil on 
substance use disorder symptom expression. One fMRI study found that administration of 
modafinil prior to a delay discounting task in persons with alcohol use disorders resulted 
increased preference for larger-later rewards, decreased activation of the ventromedial prefrontal 
cortex (reward-processing), increased activation of frontoparietal regions (inhibitory control), 
and increased connectivity among reward and inhibitory control regions (Schmaal et al., 2014). 
Another fMRI study in persons with methamphetamine dependence found that administration of 
modafinil prior to a reward-learning task resulted in increased activity in the anterior cingulate 
cortex and ventrolateral prefrontal cortex (inhibitory control) (Ghahremani et al., 2011). These 
studies suggested that modafinil may have utility as a treatment for substance use disorders. 
Indeed, modafinil has been effective in the treatment of persons with cocaine-dependence with 
and without co-morbid alcohol use disorders (Kampman et al., 2015).  
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In addition to modafinil, the pharmacological agent aripiprazole has been applied in 
persons with substance use disorders. Aripiprazole is an antipsychotic that is a partial agonist of 
DA D2 receptors. Applications of aripiprazole to persons with alcohol use disorders have resulted 
in decreased alcohol consumption over a two-week trial, as well as decreased activation of the 
right ventral striatum, a brain region associated with reward-processing (Myrick et al., 2010). 
Another fMRI study found that aripiprazole increased activation of the anterior cingulate cortex 
(inhibitory control) in response to presentation of alcohol-related cues and decreased subjective 
cravings of alcohol in persons with alcohol use disorders (Han, Kim, Choi, Min, & Renshaw, 
2013). These findings highlight the potential utility of aripiprazole for treatment of substance use 
disorders.  
Finally, Volkow’s model has informed neurocognitive “brain retraining” programs for 
substance use disorders in which patients learn to inhibit responses to disease-salient rewarding 
stimuli (e.g., drugs, alcohol) (Eberl et al., 2013). fMRI evidence shows that neurocognitive brain 
retraining programs have normalized the functioning of the mesolimbic dopaminergic system, 
thereby decreasing substance use disorder symptoms and increasing remission rates for persons 
with substance use disorders in randomized-control trials (for a review see (Cabrera et al., 
2016)).  
Application of Volkow’s model to BN will enhance understanding of neurocognitive 
dysfunction in BN and will help to contribute treatment improvement and development for BN. 
For example, results from the present study will provide a useful starting point for development 
of a novel and targeted neurocognitive “brain retraining” program that normalizes reward 
processing and, ultimately, contributes to reductions in BN symptoms. Neurocognitive 
treatments have been shown to be efficacious for several mental disorders, including for anorexia 
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nervosa (for a meta-analysis and review see Hagan and Forbush (in preparation)), but have not 
been applied to BN. Previous research also suggested that reward-processing dysfunction can be 
improved through use of the pharmacological agents modafinil and aripiprazole (Abilify), and 
this study marks a first step toward testing the effects of modafinil and/or aripiprazole on BN 
symptoms. Given that this project will elucidate associations among reward-processing and 
inhibitory control systems in BN and their effect on BN symptom expression, the results of this 
study will lay the groundwork for future neuroimaging and neurochemical studies on the 
interaction of the reward-processing, inhibitory control systems, and neurotransmitters in BN. 
The Present Study 
There is considerable interest in identifying reliable, mechanisms of BN to improve 
current treatments and inform more effective treatments. The research described above suggested 
that deficits in the inhibitory control and reward-processing systems, and an imbalance between 
these systems, may be potential mechanisms of bulimic-symptom expression. Given research 
showing that reduced availability of reward-based neurotransmitters and decreased activations of 
fronto-striatal circuits associated with inhibitory control are associated with increased binge 
eating and inappropriate compensatory behaviors in BN [e.g., (Labouliere et al., 2016; Marsh et 
al., 2011)], Volkow’s model has potential utility for characterizing BN and explaining the 
“binge-purge cycle.” In addition, one limitation of previous research is that it has not tested 
whether reward-based and inhibitory control deficits are disease-specific (i.e., food) or general 
(i.e., money) in women with BN. Research is needed to disentangle whether these processes are 
broad or specific to advance our understanding of the neurocognitive underpinnings of BN and to 
inform treatment development. 
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The purpose of the present study was to test Volkow’s model, for the first time, in 
persons with BN by testing associations among components of Volkow’s model with bulimic-
symptom expression and self-reported affect. Toward that end, the first aim of this study was to 
identify reward-processing and inhibitory control deficits in women with BN compared to 
matched healthy controls. Based on Volkow’s model and previous literature in substance use 
disorders and BN, I hypothesized that women with BN would exhibit greater reward-processing 
deficits (e.g., domains specified by Volkow’s model) than healthy controls, as demonstrated by: 
(1) working harder for monetary reward (effort valuation); (2) showing reduced ability to 
incorporate implicit feedback to earn a reward (reward learning); and (3) selecting smaller-
sooner rewards over larger-later rewards (e.g., $5 now or $10 in a week; delay discounting). I 
also hypothesized that women with BN would show decreased inhibitory control compared to 
healthy controls, as evidenced by decreased ability to inhibit response to a stimulus they are 
instructed to ignore. Additionally, an exploratory aim of this study was to test whether reward-
based processes were disease-specific (food), general (money), or both in women with BN. 
The second aim of this study was to apply Volkow’s model to BN by testing associations 
among reward-processing, delay discounting, and inhibitory control tasks in women with BN. 
Based on Volkow’s model, I hypothesized that delay discounting would positively correlate with 
effort valuation, and inversely correlate with reward learning and inhibitory control. 
Additionally, I hypothesized that inhibitory control would inversely correlate with effort 
valuation and reward learning. 
The third and final aim of this study was to test associations among facets of reward 
processing, delay discounting, inhibitory control, eating-disorder symptoms, and affective 
correlates in women with BN. I hypothesized that reward-processing and inhibitory control 
 
19 
 
dysfunction and increased delay discounting would correspond to more frequent binge eating and 
compensatory behaviors, based on research suggesting that decreased availability of reward-
based neurotransmitters and decreased activation of fronto-striatal regions associated with 
inhibitory control have been associated with increased frequency of eating-disorder behaviors 
[e.g., (Labouliere et al., 2016; Marsh et al., 2011)]. I also hypothesized that reward-processing 
and inhibitory control dysfunction and increased delay discounting would be associated with 
higher self-reported negative affect and negative urgency, and lower self-reported positive affect. 
Method 
 
 All study procedures were approved by the University of Kansas Institutional Review 
Board (IRB). All participants provided written, informed consent prior to engaging in any study-
related procedures. 
Participants 
Participant demographic characteristics are presented in Table 1, participant clinical 
characteristics are presented in Table 2, and mean values of self-report measure constructs are 
presented in Table 3. 
Women with BN. Twenty medication-free (no psychotropic medication), community 
recruited females with DSM-5 BN (confirmed with a semi-structured diagnostic interview) were 
recruited from: 1) Dr. Forbush’s existing registry of community-recruited persons with an eating 
disorder; 2) the Lawrence, Kansas community and University of Kansas campus using flyers and 
email methods; and 3) the University of Kansas Research Participant Pool system (SONA). 
Matched psychiatrically healthy control women. Twenty psychiatrically healthy 
control women (HCs) were recruited and matched to women with BN for overall equivalence on 
age, education, and racial-ethnic identification. Although I had proposed to match women with 
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BN and HCs for overall equivalence on body mass index, there were challenges in recruitment 
that rendered matching for overall equivalence on body mass index difficult. Thus, women with 
BN and HCs differed in overall (e.g., mean) body mass index; however, body mass index was 
used as a covariate in statistical analyses.  
For the purposes of this study, “psychiatrically healthy” was defined as no lifetime or 
current eating disorder, substance use disorder, major depressive disorder, generalized anxiety 
disorder, panic disorder, social phobia, and/or post-traumatic stress disorder. HCs were recruited 
using the aforementioned flyer and email methods from the Lawrence, Kansas community and 
from the University of Kansas campus, as well as through the University of Kansas Psychology 
Research Participant Pool (SONA). 
Inclusion/exclusion criteria. Inclusion criteria for all study participants were: 1) female; 
2) aged 18-30 years; and 3) fluency in written and spoken English. Exclusion criteria were: 1) 
medical conditions that affected appetite or body weight (thyroid disorder, cancer, diabetes, 
current pregnancy or post-partum, etc.); 2) neurological disorder, intellectual disability, and/or 
current psychosis; 3) current substance use disorder (due to well-documented dysfunctional 
reward processing and inhibitory control system functioning in these disorders); 4) current use of 
medications shown to affect reward circuitry or dopamine function (e.g., modafinil, second-
generation antipsychotic, amphetamine, acetylcystein, ceftriaxone, memantine, methylphenidate, 
etc.); and 5) current use of medication that affected reaction time (e.g., antihistamines or other 
sedatives in the past 24 hours). 
Screening. Medication-free (no psychotropic medication) women with BN in Dr. 
Forbush’s registry who consented to be contacted for future studies were emailed information 
about the study. The email to medication-free women with BN in Dr. Forbush’s registry 
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provided a description of the study and a link to complete the eligibility screen online via 
Qualtrics, an online survey platform supported by the University of Kansas. HCs and women 
with BN not in Dr. Forbush’s registry who responded to recruitment emails and flyers were sent 
an email with a description of the study and a link to the Qualtrics eligibility screen. 
Additionally, the eligibility screen was available as a single-credit online study in the University 
of Kansas SONA system to female students aged 18 to 30; respondents who met eligibility 
criteria for the study and consented to be contacted for participation in other studies were sent an 
email with a description of the study. 
The screen for both groups included demographic questions regarding age, education 
level, racial-ethnic identification, and height and weight (to calculate body mass index) to match 
HCs to women with BN. The Eating Disorder Diagnostic Scale (Stice, Telch, & Rizvi, 2000) 
was included to assess current eating-disorder diagnosis. Portions of the M.I.N.I. International 
Neuropsychiatric Interview (Lecrubier et al., 1997) that screened for presence of current and past 
substance use disorder, major depressive disorder, generalized anxiety disorder, panic disorder, 
social phobia, and/or post-traumatic stress disorder diagnosis were administered, as current or 
past presence of these disorders was an exclusion criterion for HCs. 
Procedure 
Study sessions were conducted in-person at the University of Kansas Center for the 
Advancement of Research on Eating Behaviors (CARE Lab) in Fraser Hall. All study sessions 
were approximately two hours in duration. Participants first reviewed the consent form and 
provided informed consent for the study with a trained undergraduate research assistant and/or 
the principal investigator (K.H.). Second, participants completed a semi-structured eating-
disorder interview, the Eating Disorder Diagnostic Interview (described below), with a trained 
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undergraduate research assistant and/or the principal investigator. Undergraduate research 
assistants were trained in interview administration by the principal investigator. Interview 
administration training included practice administration of the interview with peers and the 
principal investigator, observing the principal investigator administer the interview to one HC 
and one woman with BN, and administration of the interview to one HC and one woman with 
BN under direct/live observation of the principal investigator. The principal investigator 
provided verbal feedback and collaboratively reviewed paper copies of the interview with 
undergraduate research assistants. Once an undergraduate research assistant was cleared to 
independently administer interviews, undergraduate research assistants were asked to audiotape 
the interview (if the participant agreed to be audiotaped, by checking the appropriate box in the 
consent form and initialing) and the principal investigator reviewed audiotapes along with 
corresponding paper copies of the interview. Ten percent of audiotapes were randomly selected 
to compute inter-rater reliability. 
During the semi-structured eating-disorder interview, objective height and weight 
measurements were obtained. Next, participants completed self-report measures on a laptop via 
the Qualtrics platform. Within Qualtrics, the order of self-report measure completion was 
randomized across participants. Upon completion of self-report measures, behavioral tasks were 
administered to participants. The order of behavioral tasks was counter-balanced across 
participants. Finally, participants were debriefed and compensated. Participants recruited through 
Dr. Forbush’s registry and from the Lawrence, Kansas community and University of Kansas 
campus through flyer and email methods were compensated for their time and participation with 
$50 in the form of a debit or gift card. Participants recruited via SONA were presented the option 
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of compensation through SONA credits (up to four credits) or $50 in the form of a debit or gift 
card for their time and participation. 
Measures 
Behavioral tasks.  
Reward learning. The Probabilistic Reward Learning Task (Pizzagalli, Jahn, & O'Shea, 
2005) is a computerized task that was used to test reward learning. The Probabilistic Reward 
Learning Task has been used to examine reward learning in women with recovered BN (Grob et 
al., 2012). Participants are instructed that the goal of the Probabilistic Reward Learning Task is 
to earn as much money as possible; money “earned” via the Probabilistic Reward Learning Task 
was hypothetical (i.e., participants were not additionally compensated for performance). Prior to 
completing the task, participants reviewed instructions with the experimenter and engaged in two 
practice trials with the experimenter in the room in order to facilitate understanding. The task 
consisted of three blocks of 100 trials, and 30 seconds separated each block. Each trial began 
with presentation of a fixation cross for 500 milliseconds (ms). Next, a “mouthless” face was 
presented for 500 ms. Then, a face with either a short mouth (11.5 millimeters) or a long mouth 
(13 millimeters) was presented for 100 ms. The mouthless face was again presented while 
participants identified whether they saw a short mouth or a long mouth by pressing the “m” key 
or the “v” key on a standard computer keyboard. Mouth length associated with reward (e.g., 
short or long) and keys used to identify mouth length (“m” and “v” keys) were counterbalanced 
across participants. Participants were asymmetrically reinforced on their response; specifically, 
only 40 (30 rewarding mouths and 10 non-rewarding mouths) of the 100 trials in each block are 
reinforced with, “Correct!! You won 20 cents.” An equal number of short and long mouths are 
presented in each block and no more than three consecutive repetitions of the same mouth length 
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were permitted. Reward learning measured by the Probabilistic Reward Learning Task has 
demonstrated evidence for test-retest reliability in a university-student sample over 
approximately one month (average 38.28 days between administrations), with a correlation of 
r=0.57 (p=0.003) between administrations, (Pizzagalli et al., 2005). 
The main variable of interest for the Probabilistic Reward Learning Task was response 
bias, which corresponds to the participant’s preference for the mouth (either short or long, 
depending on counterbalancing assignment) that yields the most reward. Additionally, we were 
interested in participant ability to correctly discriminate short and long mouths, which is termed 
discriminability. Discriminability was entered as a covariate in statistical analyses. 
Inhibitory control. A computerized go/no-go task adapted from Batterink, Yokum, and 
Stice (2010) was used to assess inhibitory control toward specific (i.e., food) and generalized 
(i.e., “pleasant” animal images) pleasurable stimuli in order to test whether inhibitory control 
deficits might be a specific or general process in women with BN. “Pleasant” animal images and 
food images were normed for palatability, intensity, and valence. Participants were instructed to 
respond (“go”) as quickly and accurately as possible to images framed in blue or yellow 
(depending on task version assigned via counterbalancing; see below) by pressing the “1” key on 
a computer keyboard and to withhold response (“no-go”) to images framed in blue or yellow. 
The go/no-go task consisted of four blocks of 112 trials. “Go” cues consisted of 75% of the trials 
and “no-go” cues comprised 25% of the trials. Two versions of the go/no-go task were 
administered; one version asked participants to “go” to images framed in blue and “no-go” to 
images framed in yellow, whereas the other version instructed participants to “go” to images 
framed in yellow and “no-go” to images framed in blue. Task version was counterbalanced 
across participants. The outcome variable of interest was the number of commission errors (an 
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index of inhibitory control) – pressing a key for the “no-go” stimulus – made by a participant. 
Batterink et al. (2010) administered the go/no-go task to participants while they simultaneously 
underwent an fMRI scan, and results showed elevated activity in the superior and inferior frontal 
gyrus during no/go (vs. go) trials. The superior and inferior frontal gyrus activity have been 
linked to response inhibition (Nakata et al., 2008); thus, Batterink et al. (2010)’s go/no-go task 
appeared to engage the inhibitory control system. Data for two participants with BN were 
omitted from analyses because their responses indicated that they reversed instructions and 
pressed the “1” key for “no-go” trials and withheld response for “go” trials. 
Self-report measures. 
Demographics. A researcher-designed demographics questionnaire assessed participant 
age, racial-ethnic identification, education level, treatment history, current medication usage (to 
verify medication-free status), nicotine use, and highest and lowest lifetime body weights at 
current height.  
Menstrual cycle phase information. I collected self-reported information regarding the 
start and end dates of the most recent menstrual period, typical duration of menstrual periods, use 
of hormonal contraceptive methods, and reproductive stage (e.g., menopause), due to evidence 
that menstrual cycle phase can influence reward-processing function (Dreher et al., 2007). 
Participants were not matched on menstrual cycle phase and use of contraceptives due to the 
challenges this would have created with recruitment and matching groups; however, these 
variables were used as covariates in statistical analyses if there were group differences. 
Delay discounting. Delay discounting was tested using the 27-item Monetary Choice 
Questionnaire (Kirby, Petry, & Bickel, 1999), which is featured in the National Institutes of 
Health PhenX Toolkit, and an experimenter-designed Food Choice Questionnaire. Use of the 
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Monetary Choice Questionnaire and Food Choice Questionnaire enabled us to test whether delay 
discounting was generalized (money) and/or specific (food) process in persons with BN. The 
Monetary Choice Questionnaire asked the participant to select whether they preferred 
hypothetical smaller amounts of money now or larger amounts of money later (delay). Previous 
research indicated that use of hypothetical commodities yields results similar to use of real 
commodities (Lawyer, Schoepflin, Green, & Jenks, 2011). The Monetary Choice Questionnaire 
has demonstrated evidence for good test-retest reliability as well as temporal stability over one 
year and 57 weeks (Kirby, 2009).  
A 27-item experimenter-designed Food Choice Questionnaire based on the Monetary 
Choice Questionnaire was used to test specific delay discounting. Participants were asked to 
identify their favorite snack food and how many servings of the snack food were worth $100 to 
them; thus, the commodity (favorite snack food) and equivalency amount (servings) were 
individualized for each participant. The favorite snack food and amount of servings were then 
input into Reed and Jarmolowicz (2013)’s Customizable Commodity Choice Excel Software to 
create a unique, individualized Food Choice Questionnaire. The Customizable Commodity 
Choice Software is based on the Monetary Choice Questionnaire.  
The outcome variable of interest for both the Monetary Choice Questionnaire and the 
Food Choice Questionnaire was k, a value that represents the degree of delay discounting. 
Smaller values of k are reflective of a preference for larger-later rewards, whereas larger k values 
are reflective of a preference for smaller-sooner rewards. 
Effort valuation. A food-specific hypothetical purchase task was developed based on the 
Alcohol Purchase Task (Murphy, MacKillop, Skidmore, & Pederson, 2009) and used to measure 
effort valuation. Our food-specific hypothetical purchase task measured the relative reinforcing 
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efficacy of food. Participants were asked to consider how many commodities of their favorite 
food they would be willing to purchase for 17 different prices, ranging from $0 (free) to $20.00. 
Each participant’s reported food consumption is plotted as a function of price into a 
demand curve, which yields several outcome variables of interest. One outcome variable is the 
intensity of the demand, or the number of food portions “consumed” when food portions cost 
$0.00 (i.e., food portions are free). A second outcome variable is maximum food portion 
consumption, termed Omax. A third outcome variable is the price-point at which the food demand 
becomes “elastic,” or when number of snack servings purchased decreases significantly faster 
than price increases, known as Pmax. A final outcome variable of interest and the main variable of 
interest in this study is breakpoint, or the price at which food consumption completely ceases 
(i.e., no portions of food are purchased and consumed). All outcome variables (intensity, Omax, 
Pmax, and breakpoint) were empirically derived for this study, and the main outcome variable of 
interest for this study is breakpoint, as it is a proxy variable for how much effort one puts 
forward to obtain the reward. 
The psychometric properties of our food-specific purchase task are not known. However, 
the hypothetical purchase task has been widely used to study other commodities of interest, 
including alcohol (Murphy et al., 2009), indoor tanning (Reed, Kaplan, Becirevic, Roma, & 
Hursh, 2016), and cigarettes (MacKillop et al., 2008). Moreover, the alcohol-based hypothetical 
purchase task (Alcohol Purchase Task) has demonstrated good-to-excellent test-retest reliability 
over two-week periods (Murphy et al., 2009) as well as construct validity (i.e., high correlation; 
r=.87) between hypothetical alcohol consumption measured by the Alcohol Purchase Task and 
actual alcohol consumption in a laboratory setting (Amlung, Acker, Stojek, Murphy, & 
MacKillop, 2012). 
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Eating Pathology Symptoms Inventory (EPSI). The 45-item EPSI (Forbush et al., 2013) 
was used to assess self-reported disordered-eating symptoms over the past four weeks. The EPSI 
was used to address the third goal of this study, which was to examine associations among 
reward-processing and inhibitory control deficits and eating-disorder symptoms. The EPSI is 
comprised of eight subscales: Body Dissatisfaction (feeling badly about one’s body shape and/or 
weight); Binge Eating (eating large amounts of food in a distinct period of time and experiencing 
a subjective loss-of-control); Restricting (successful caloric restriction to influence body weight 
and/or shape); Cognitive Restraint (attempts – successful or not – to restrict caloric intake to 
influence body weight and/or shape); Excessive Exercise (intensive exercise lasting two or more 
hours); Purging (forced expulsion of calories from the body, including self-inducing vomiting 
and use of diet pills, laxatives, and/or diuretics); Muscle Building (dissatisfaction with muscle 
size and use of substances to increase muscle mass); and Negative Attitudes Towards Obesity 
(negative beliefs about and emotional reactions to persons with overweight or obesity). In this 
study, only the Binge Eating, Restricting, Excessive Exercise, and Purging scales were used to 
assess self-reported levels of binge-eating and inappropriate compensatory behaviors. 
The EPSI scales have demonstrated evidence for strong psychometric properties. The 
EPSI scales have demonstrated good-to-excellent internal consistency (Forbush et al., 2013) and 
good test-retest reliability over periods of two and four weeks (Forbush, Hilderbrand, Bohrer, & 
Chapa, 2017; Forbush et al., 2013); however, reliabilities for the Muscle Building scale were 
lower for women than men. The EPSI scales have shown evidence for excellent discriminant 
validity from mood- and anxiety-related measures and moderate-to-strong convergent validity 
with other eating-disorder-related measures (Forbush, Wildes, & Hunt, 2014; Forbush et al., 
2013). The EPSI scales have also shown evidence for criterion-related validity, because they 
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have differentiated eating-disorder cases from non-eating disorder cases (Forbush et al., 2013). 
Finally, the EPSI scales have shown evidence for construct validity in both men and women 
(Forbush et al., 2013); however, the Muscle Building scale did not perform as well in women as 
in men. Decreased psychometric performance of the Muscle Building scale in women versus men 
could be attributed to women having less desire to increase muscle mass. Due to the EPSI’s 
strong psychometric properties, the National Institutes of Health has included the EPSI in its 
PhenX Toolkit of recommended measures. Internal consistency of the EPSI scales used in this 
study was acceptable-to-excellent, as Cronbach’s alpha values ranged from 0.73 for Purging to 
0.954, 0.907, and 0.921 for Binge Eating, Excessive Exercise, and Restricting, respectively. 
Externalizing Spectrum Inventory – Brief Form (ESI-bf). The 160-item ESI-bf (Patrick, 
Kramer, Krueger, & Markon, 2013) was developed from the original 415-item ESI (Krueger, 
Markon, Patrick, Benning, & Kramer, 2007) and assesses three higher-order dimensions and 23 
lower-order facets of externalizing symptoms (detailed below). The three factor-analytically 
derived higher-order dimensions of the ESI-bf include a general Externalizing factor comprised 
of two sub-factors: Callous-Aggression (non-empathic, deviant behaviors characteristic of 
psychopathy) and Substance Abuse (problems with use of marijuana, other drugs, and alcohol). 
Twenty-three factor-analytically derived sub-scales of the three higher-order factors include 
scales that assess aggression, destruction of property, impulsivity, sensation-seeking, empathy, 
and use and problems with use of drugs, marijuana, and alcohol. The ESI-bf scales have 
demonstrated evidence for strong psychometric properties in male and female college-student 
and prisoner populations. For example, the ESI-bf scales have demonstrated good-to-excellent 
internal consistency on all scales in college-student and prisoner populations (’s>0.85)(Patrick 
et al., 2013). The ESI-bf also demonstrated evidence for criterion-related validity with similar 
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scales on a self-report measure of positive and negative emotionality. In this study, only the 
Substance Abuse factor scale will be used to assess substance use. Internal consistency of the 
Substance Abuse factor scale in this sample was marginal, with a Cronbach’s alpha value of 
0.603. Poor internal consistency within the Substance Abuse factor may be due to the fact that 
presence of a substance use disorder was an exclusion criterion for this study, which may have 
led to range restriction and lowered correlations among items. 
Inventory of Depression and Anxiety Symptoms-II (IDAS-II). The 99-item IDAS-II 
(Watson et al., 2012) was used to assess symptoms associated with mood and anxiety disorders 
over the past two weeks on a 5-point Likert that ranges from “not at all” to “extremely.” The 
IDAS-II was used to test the third goal of this study. Part of the third goal of this study was to 
examine the associations of reward-processing and inhibitory control dysfunction with self-
reported affect. The IDAS-II assesses symptoms related to depression, mania, obsessive-
compulsive disorder, post-traumatic stress disorder, social phobia, specific phobia, agoraphobia, 
and panic disorder via 18 factor-analytically distinct scales. The IDAS-II scales have 
demonstrated evidence for acceptable-to-excellent internal consistency in college-student 
(’s=0.76-0.88), community adult (’s=0.72-0.90), and patient (’s=0.79-0.90) samples 
(Watson et al., 2012). In the current study, the IDAS-II scales demonstrated evidence for good-
to-excellent internal consistency (’s=0.807-0.946). Additionally, the IDAS-II scales have 
shown good convergent validity in comparison to related mood and anxiety self-report measures 
and clinical interviews on obsessive-compulsive (mean convergent r’s=0.72 and 0.59 for self-
report and interview, respectively), trauma-related (mean convergent r’s=0.73 and 0.60 for self-
report and interview, respectively), social anxiety (convergent r’s=0.53-0.68), claustrophobic 
(convergent r=0.51), and manic (r’s=0.44-0.56) symptoms. The IDAS-II scales have also 
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demonstrated evidence for discriminant validity because convergent correlations were greater 
than all discriminant correlations (Watson et al., 2012). Finally, each of the IDAS-II scales 
demonstrated evidence for criterion-related validity with their corresponding DSM-IV diagnosis. 
In sum, the IDAS-II scales have demonstrated evidence for strong psychometric properties. 
Positive and Negative Affect Schedule (PANAS). The 20-item PANAS (Watson, Clark, 
& Tellegen, 1988) was used to assess current positive and negative affect and their association 
with reward-processing and inhibitory control dysfunction, which is the third goal of this study. 
The Positive and Negative Affect scales each consist of ten items each and items are rated on 5-
point Likert scale, anchored in “not at all” to “very much.” The two-factor structure of the 
PANAS has been replicated (Crawford & Henry, 2004). Both the Negative (’s=0.86-0.89) and 
Positive (’s=0.85-0.87) Affect scales have demonstrated evidence for good-to-excellent internal 
consistency for different time instructions (e.g., ratings for that moment, today, past few days, 
year, in general) (Crawford & Henry, 2004; Watson et al., 1988). In this sample, the Negative 
(=0.906) and Positive (=0.881) Affect scales demonstrated evidence for good-to-excellent 
internal consistency. Eight-week test-retest reliabilities for both the Positive and Negative Affect 
scales were significantly positively correlated for all time instructions (Watson et al., 1988). In 
addition to evidence for strong reliability, the Negative Affect scale has demonstrated evidence 
for convergent validity with self-report measures of depression and anxiety, and the Positive 
Affect scale has demonstrated evidence of discriminant validity with self-report measures of 
depression and anxiety (Crawford & Henry, 2004). The PANAS is the most widely used measure 
of affect in eating-disorders EMA research (Berg et al., 2013; Lavender et al., 2016). 
UPPS-P Impulsive Behavior Scale. The 59-item UPPS-P (Lynam, Smith, Whiteside, & 
Cyders, 2006) assesses cognitive and behavioral impulsivity across five scales: (Negative) 
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Urgency, (lack of) Premeditation, (lack of) Perseverance, Sensation Seeking, and Positive 
Urgency. Only the (Negative) Urgency scale was used in this study in order to address third goal 
of my study, part of which was to examine the associations among negative urgency, reward 
processing, and inhibitory control deficits. The UPPS-P scales have demonstrated evidence for 
strong psychometric properties. Regarding reliability, UPPS-P scales have shown evidence for 
good-to-excellent test-retest reliability over a period of approximately one week (r’s=0.81-0.93) 
(Weafer, Baggott, & de Wit, 2013). The UPPS-P scales have also provided evidence for good-to-
excellent internal consistency (’s=0.82-0.94) (Cyders, 2013). In this sample, the UPPS-P scales 
demonstrated evidence for good-to-excellent internal consistency (’s=0.859-0.943), except for 
the (lack of) Perseverance scale (=0.519), which was not used in analyses. Regarding validity, 
the UPPS-P scales have provided evidence for criterion-related validity in predicting antisocial, 
binge eating, and problematic drinking and gambling behavior (Smith et al., 2007). The UPPS-P 
scales have demonstrated measurement invariance across sex, suggesting that the UPPS-P scales 
have construct validity in both men and women (Cyders, 2013). Finally, the UPPS-P scales have 
demonstrated evidence for convergent and discriminant validity across assessment method (e.g., 
interview versus self-report) (Smith et al., 2007). 
 Semi-structured interview.  
Eating Disorder Diagnostic Interview (EDDI). The EDDI (Presnell & Stice, 2003) is a 
brief interview adapted from the widely used Eating Disorders Examination (Fairburn & Cooper, 
1993). The EDDI assesses frequency of eating-disorder behaviors (e.g., binge eating, 
inappropriate compensatory behaviors), presence of eating-disorder-related cognitions (e.g., 
overvaluation of weight/shape), and weight history (e.g., current, highest, and lowest weights) 
over the past year. In the present study, inter-rater reliability was excellent for objective binge 
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eating episodes (ICC=1.00), self-induced vomiting episodes (ICC=1.00), diuretic and laxative 
misuse episodes (ICC=1.00), fasting episodes (ICC=1.00), and compensatory exercise episodes 
(ICC=1.00). Collection of binge-eating and inappropriate compensatory behaviors (e.g., self-
induced vomiting) episode frequencies allowed me to derive and confirm current DSM-5 BN 
diagnoses. Frequency of binge-eating and inappropriate compensatory behaviors episodes were 
used to test the third aim of my study, part of which was to examine the association of these 
behaviors with reward-processing and inhibitory control. 
Objective height and weight measurements. Height was assessed using a wall-mounted 
stadiometer and weight was measured with a digital scale. These measurements were used to 
compute objective body mass index (kg/m2).  
Statistical Analysis 
 Data were analyzed using R statistical software (R Core Team, 2018) and IBM SPSS 
Version 25 (IBM Corp, 2017). Participant demographic characteristics and clinical 
characteristics were compared using parametric or nonparametric independent samples t-tests 
and effect sizes for continuous variables and 2 tests for categorical variables. 
Aim One. The first aim of this study was to compare distinct reward-processing 
components in women with BN compared to matched HCs. For inhibitory control data (go/no-go 
task), mean differences in commission errors were examined using general linear models and 
body mass index was entered as a covariate.  
Delay discounting data (Monetary Choice Questionnaire; Food Choice Questionnaire) 
were screened for inconsistency and datasets with consistency values less than 75% were 
excluded from analyses. Delay discounting values (i.e., k values) rendered for the Monetary 
Choice Questionnaire and Food Choice Questionnaire were non-normally distributed. As such, k 
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values were natural-logarithm transformed, in accordance with Jarmolowicz, Lemley, Cruse, and 
Sofis (2015). After natural-logarithm transformation, k-values were normally distributed and 
general linear models, with body mass index entered as a covariate, were used to test mean 
differences in delay discounting between groups. 
For reward learning (Probabilistic Reward Learning Task), general linear mixed models 
were used to test differences in response bias to mouth length using a group (BN, HC) by task 
block (1, 2, 3) model, and discriminability and body mass index were entered as covariates. In 
addition, a reward learning score was calculated for each participant by subtracting their 
response bias score in the first block from their response bias score in the third (final) block of 
the task; group mean differences in reward learning were examined using an independent 
samples t-test. Prior to analyses, Probabilistic Reward Learning Task data were evaluated for 
quality along four different criteria (detailed in the following sentences), based on procedures 
established by Pizzagalli et al. (2005). First, data were checked for validity, or reaction times 
slower than 150 ms per block; previous recommendations suggested that at least 80% of trials in 
each of the three blocks needed to be valid for inclusion in analyses. Second, the ratio of “rich” 
and “lean” trials given feedback (i.e., “Correct!! You won 20 cents.”) in each block was 
evaluated to ensure that the rich-to-lean feedback ratio was close to 3:1. Data with rich-to-lean 
feedback ratios less than 2.5:1 per block were excluded, in line with Pizzagalli et al. (2005). 
Third, data were evaluated for “outliers” or trials with reaction times faster than 150 ms, slower 
than 2500 ms, or three standard deviations above or below the mean reaction time; no more than 
10 outliers per block or 30 overall outliers were permitted. Finally, data were evaluated for 
accuracy in discriminating short and long mouths; data with >55% accuracy per block (i.e., 
slightly greater than chance) were included.  
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For effort valuation (food-specific hypothetical purchase task), data were analyzed using 
the R beezdemand (Kaplan, 2018) package, which was built specifically to analyze hypothetical 
purchase task data. In line with approaches from past hypothetical purchase task analyses, raw 
food purchase task data were examined for outliers (defined as > four standard deviations above 
or below the mean number of snack servings purchased at each price point) and outliers were 
replaced with the next-highest non-outlying value (Kaplan & Reed, 2018). Next, raw data were 
screened for non-systematic patterns of responding, based on three criteria proposed by Stein, 
Koffarnus, Snider, Quisenberry, and Bickel (2015): 1) bounce (i.e., increases in number of food 
servings purchase with increasing price; this criterion requires that  10% of a participant’s 
servings purchased increase with increasing price and that the increases in portions purchased are 
 25% greater than the amount of food servings purchased when food servings were free); 2) 
reversals from zero (i.e., purchase of food servings resumes at a higher price after the respondent 
did not purchase any food servings for two consecutive price points); and 3) trend (i.e., purchase 
of food servings decreases with increasing price, such that there is at least a 0.025 log-unit 
decrease in food purchase per long-unit change in price). Participant datasets that passed all three 
of Stein et al. (2015)’s criteria were used in analysis. Outcome variables of interest (breakpoint, 
intensity, Omax, and Pmax) were then empirically derived and, consistent with previous research 
(Kaplan & Reed, 2018), were screened for outliers  3.29 standard deviations away from the 
mean for each outcome variable; outliers were recoded as the next highest (or lowest) non-
outlying value. Next, intensity, Omax, Pmax, and breakpoint were not normally distributed; as such, 
these variables were square-root transformed (to account for zero values) and examined for 
normality. Intensity, Omax, Pmax, and breakpoint remained non-normally distributed after 
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transformation; thus, non-parametric Mann-Whitney U tests were performed to examine 
differences in groups across demand measures.  
Aim Two. The second aim of the study was to apply Volkow’s reward-processing model 
to women with BN. Due to non-normality of the distributions of some outcome variables, 
Spearman’s rank-order correlations were used to test correlations among the four aspects of 
Volkow’s model in women with BN: delay discounting (Monetary Choice Questionnaire; Food 
Choice Questionnaire), reward learning (Probabilistic Reward Learning Task), effort valuation 
(food-specific hypothetical purchase task), and inhibitory control (go/no-go task). Additionally, 
two mediational models were tested using non-parametric bootstrapping in the R (R Core Team, 
2018) mediation package (due to relatively small sample size): (1) reward learning mediating the 
association between delay discounting and inhibitory control; and (2) delay discounting 
mediating the association between reward learning and inhibitory control. 
 Aim Three. The third aim of the study was to test associations among reward-processing 
and inhibitory control tasks, bulimic symptoms, and affect. Associations among binge eating and 
inappropriate compensatory behaviors frequencies (EDDI), self-reported positive and negative 
affect (PANAS, IDAS-II), negative urgency (UPPS-P), and the four components of Volkow’s 
model [delay discounting (Monetary Choice Questionnaire; Food Choice Questionnaire), reward 
learning (Probabilistic Reward Learning Task), effort valuation (food-specific hypothetical 
purchase task), inhibitory control (go/no-go task)] were tested using non-parametric Spearman’s 
rank-order correlations due to non-normally distributed variables. 
Results 
Aim One 
 The first aim of this study was to identify reward-processing deficits in women with BN 
compared to matched HCs. Results for each measure are presented in Table 4. 
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Inhibitory control. Data for two participants with BN were omitted from analyses 
because participants reversed directions and responded to no-go images and withheld response to 
go images. Women with BN (vs. HCs) made more commission errors toward “pleasant” animal 
images (medium effect size) and more commission errors toward food images (small-to-medium 
effect size). However, women with BN did not significantly differ from matched HCs on both 
number of commission errors toward “pleasant” animal images (e.g., general) and food images 
(e.g., specific). Additionally, results suggested no differences in inhibitory control between 
general (pleasant animal) and disease-specific (food) images in women with BN, t(17)=-0.954, 
p=0.353. 
Delay discounting. Data from the Food Choice Questionnaire were excluded from 
analyses for three participants. One HC and one woman with BN did not fully complete the Food 
Choice Questionnaire and data from one HC demonstrated inconsistent responding. Thus, there 
were complete and usable datasets from 19 women with BN and 18 HCs. All datasets from the 
Monetary Choice Questionnaire were included, as there was no evidence of inconsistent 
responding or missing data. Contrary to my hypothesis, women with BN showed significantly 
greater preference for larger-later (vs. smaller sooner) monetary (general) and food (specific) 
commodities compared to HCs. The effect sizes for both monetary commodities and food 
commodities was large. Additionally, results suggested that women with BN showed increased 
discounting of delayed food versus monetary commodities, t(18)=-2.617, p=0.017, suggesting 
that delay discounting may be more pronounced toward food commodities. 
Reward learning. Following data screening procedures established by Pizzagalli et al. 
(2005), data for five women with BN and two HCs did not pass the quality check and were 
excluded from analyses. Results from the Probabilistic Reward Learning Task showed a 
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significant task block by diagnosis interaction and women with BN demonstrated significantly 
less response HCs. However, response biases did not differ between women with BN and HCs 
for the second and third blocks of the task (see Figure 2). Women with BN and HCs 
significantly differed in overall reward learning, such that women with BN showed significantly 
greater reward learning over the task than HCs. The significant difference in reward learning 
between groups can be attributed to the fact that HCs learned stimulus-reward associations 
quickly in the first block of the task and did not show learning throughout the remaining two 
blocks of the task because of relatively rapid learning in the first block. On the other hand, 
women with BN did not learn stimulus-reward associations as quickly (evidenced by poor 
performance in the first block of the task) but learned stimulus-reward associations over the 
course of the task and “caught up” to HCs.  
Effort valuation. One woman with BN did not complete the measure and her dataset was 
excluded from analyses. The dataset for one woman with BN did not pass Stein et al. (2015)’s 
criteria and her data were excluded from analyses; all other datasets passed criteria for systematic 
responding and were included, for a total of n=18 women with BN and n=20 HCs. One woman 
with BN had an extreme outlier in her raw data (2,000,000 portions of her favorite food) and this 
number was recoded to the next-highest value of 100. There was one outlier for demand 
measures; a HC had an extreme outlier for Omax of 120 and this value was replaced with the next-
highest value of 80.  
The primary measure of interest was breakpoint. Compared to HCs, women with BN did 
not have significantly higher breakpoints. However, women with BN (vs. HCs) consumed 
significantly more food portions when the cost was $0.00 and had significantly higher maximum 
food portion consumptions (Omax). Groups did not significantly differ on Pmax, the price-point at 
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which the food demand becomes “elastic,” or a one-unit change in cost is associated with a one-
unit change in number of food portions consumed. Finally, a graphic of demand curves by group 
is presented in Figure 3. 
Aim Two 
 The second aim of the study was to apply Volkow’s reward-processing model to women 
with BN. Results are presented in Table 5 and Figure 4. There was partial support for Volkow’s 
model in this sample. Increased discounting of monetary values was significantly associated with 
elevated inhibitory control to both food and “pleasant” animal images; however, there were no 
significant associations between discounting of food commodities and inhibitory control. In 
addition, preference for smaller-sooner food commodities was associated with greater 
breakpoints (effort valuation) for food commodities; delay discounting of monetary commodities 
and breakpoint were not significantly associated. Finally, preference for larger-later commodities 
of food increased as reward learning increased; however, there were no associations with reward 
learning and discounting of monetary commodities. Inconsistent with Volkow’s model, there 
were no significant associations among inhibitory control and reward learning, nor inhibitory 
control and effort valuation. 
Aim Three 
 The third aim of the study was to test associations among reward-processing and 
inhibitory control tasks, bulimic symptoms, and affect in women with BN. Frequency of fasting 
episodes over the past three months significantly decreased with decreased inhibitory control 
toward “pleasant” animal images. Additionally, frequency of compensatory exercise episodes 
over the past three months significantly decreased with decreased inhibitory control toward food 
images on the go/no-go task. Finally, reduced reward learning in the first block of the 
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Probabilistic Reward Learning Task was associated with increased frequency of self-induced 
vomiting episodes; however, overall reward learning and reward learning in the second and third 
blocks of the Probabilistic Reward Learning Task was not associated with self-induced vomiting 
frequencies in BN. There were no other significant relationships among reward-processing and 
inhibitory control measures and bulimic symptoms. 
There were three significant associations among reward-processing and inhibitory control 
measures and affect. First, reward learning significantly increased as UPPS-P Negative Urgency 
decreased. Second, preference for smaller-sooner amounts of food (delay discounting) increased 
as UPPS-P Negative Urgency increased. Finally, preference for smaller-sooner commodities of 
money increased as PANAS Positive Affect decreased. 
Discussion 
 
 The present study was the first application of Volkow’s transdiagnostic model of reward 
processing and inhibitory control to women with BN. Volkow’s model contends that imbalances 
among three different reward-processing components (delay discounting, reward learning, and 
effort valuation) and inhibitory control maintain symptom expression in persons with substance 
use disorders. Given certain parallels between reward-processing dysfunction in persons with 
substance use disorders and BN, as well as data from nationally representative samples 
suggesting that 36.8% of persons with BN will have a substance use disorder in their lifetime 
(Hudson et al., 2007), I proposed that Volkow’s model might have utility for improved 
understanding of the neurocognitive mechanisms underlying BN. An additional aim of the 
present study was to determine whether reward-processing dysfunction was general or eating-
disorder specific.  
Reward-Processing and Inhibitory Control Functioning in Bulimia Nervosa  
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The first aim of the present study was to identify differences in reward processing and 
inhibitory control (e.g., domains specified by Volkow’s model) between women with BN and 
matched HCs. I hypothesized that women with BN would exhibit greater reward-processing 
deficits and poorer inhibitory control than HCs. As I describe below, support for this hypothesis 
was mixed.  
Effort valuation. Women with BN and HCs did not significantly differ in effort 
expended (breakpoint) to consume food commodities (effort valuation) on a food-specific 
hypothetical purchase task. The null finding for differences in effort valuation (breakpoint) 
between women with BN and HCs was not consistent with results of two previous studies that 
found women with BN had significantly higher breakpoints for food reward than HC women on 
behavioral progressive ratio tasks (Bodell & Keel, 2015; Schebendach et al., 2013). Although 
participants from the present study had similar ages and educational statuses, the present study 
differed from past research by using more rigorous exclusion criteria. For example, current 
alcohol and substance use disorders were not exclusion criteria for Bodell and Keel (2015), 
whereas current alcohol and/or substance use disorder were exclusion criteria for this study. Prior 
research suggested that substance use disorders are associated with greater effort expenditure for 
reward (MacKillop et al., 2008; Murphy et al., 2009); thus, Bodell and Keel’s (2015) finding that 
women with BN expend more effort to obtain a food reward may be due to the presence of 
current alcohol and substance use disorder co-morbidities in their sample. Another difference in 
the current effort valuation tasks and previous research is that Schebendach et al. (2013) 
instructed participants to overeat or “binge” while completing the progressive ratio task. In the 
present study, and in Bodell and Keel (2015), participants were not instructed to “binge” or 
overeat. Thus, the very large difference in breakpoints between women with BN versus HCs seen 
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in Schebendach et al. (2013) compared to the null effect in the present study may be due to 
differences task instructions.  
In the future, it will be important to disentangle whether increased breakpoint toward 
food reward is associated with BN or unique to persons with co-morbid BN and 
alcohol/substance use disorders. Additionally, it will be useful to examine whether differences in 
breakpoint toward food reward vary under “binge” and non-binge instruction conditions in BN. 
Future research on effort valuation in BN is important because it will allow the field to 
understand whether effort valuation represents a dysfunctional mechanism that could be targeted 
in future treatments for BN. 
Inhibitory control. Women with BN and HC women did not significantly differ on a 
behavioral task of proactive inhibitory control (inhibition of a response that is not yet underway) 
in the present study. Groups showed similar ability to inhibit response to a stimulus they were 
instructed to ignore. Results were consistent with a meta-analysis of inhibitory control that found 
that persons with BN showed less proactive inhibitory control compared to HCs on the go/no-go 
task (g=-0.26; small effect) (Wu, Hartmann, et al., 2013). Although groups in the present study 
did not demonstrate statistically significant differences on an inhibitory control task, the effect 
sizes found in the present study were greater than effect sizes found in Wu, Hartmann et al. 
(2013). Specifically, in this study, women with BN (vs. HCs) showed less inhibitory control 
toward both disease-specific (food; d=-0.42/g=-0.41, small-to-moderate effect) and general 
(animal; d=-0.53/g=-0.53, moderate effect) images. In addition, results from the present study 
suggested that inhibitory control is a both a general and eating-disorder-specific process in 
women with BN, as the number of commission errors on the go/no-go task did not significantly 
differ between food (disease-specific) and pleasant animal (general) images.   
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 Delay discounting. Women with BN showed a preference for larger-later rewards over 
smaller-sooner rewards (delay discounting) compared to HC women; thus, women with BN 
showed less discounting than HC women. This finding contradicts my hypothesis that women 
with BN would show greater (not less) preference for smaller-sooner reward than their healthy 
counterparts. Prior research demonstrated that participants with BN and binge-eating syndromes 
show increased discounting of delayed monetary reward (i.e., preference for smaller-sooner 
reward) compared to HCs (Kekic et al., 2016; McClelland et al., 2016). One limitation of prior 
research is that only one study of delay discounting (with monetary commodities) has been 
conducted in persons with BN compared to HCs (Kekic et al., 2016). Thus, more research is 
needed to understand the nature of delay discounting in BN. Past research has demonstrated that 
persons with anorexia nervosa, an eating disorder characterized by objectively low body weight 
maintained through chronic dietary restriction, is associated with increased preference for larger-
later (vs. smaller sooner) reward compared to HCs (Decker, Figner, & Steinglass, 2015; 
Steinglass et al., 2012). Given the frequency of diagnostic crossover between BN and anorexia 
nervosa (due to fluctuations in body mass index) (Eddy et al., 2008; Schaumberg et al., 2018), an 
important future direction will be to further understand if past history of anorexia nervosa 
influences delay discounting in persons with current BN. 
Reward learning. Results from the present study support differences in reward learning 
between women with BN and HC women. In particular, women with BN (vs. HC women) took 
significantly longer to learn implicit stimulus-reward associations during the Probabilistic 
Reward Learning Task. Specifically, in the first block of the Probabilistic Reward Learning 
Task, women with BN (vs. HC women) demonstrated significantly lower ability to learn 
stimulus-response associations between mouth length and hypothetical monetary reward. 
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However, reward-learning performance was similar for both groups at the end of the reward 
learning task, suggesting that women with BN were slower to learn associations, but eventually 
caught up to HCs. Findings are consistent with those of Labouliere et al. (2016), who found that 
adults with BN (vs. healthy controls) showed reduced ability to incorporate feedback to improve 
response accuracy on the first three (of five) blocks of an implicit reward-learning task and then 
showed reward learning performance commensurate to matched HCs in the last two blocks of the 
task. Taken together, findings from the present study and previous research suggest that persons 
with BN (vs. HCs) take longer to learn stimulus-response associations but eventually “catch up” 
to their healthy counterparts. 
Challenges with integrating stimulus-response associations may affect ability to modulate 
behavior as a function of reinforcement history and, ultimately, contribute to disease 
maintenance in persons with BN. Results compliment Fairburn, Cooper, and Shafran (2003)’s 
Trans-Diagnostic Model of Eating Disorders, which suggests that persons with BN do not learn 
that extreme weight-control behaviors, such as fasting and excessive exercise, are associated 
with subsequent binge eating and become “stuck” in a vicious cycle of extreme weight-control 
behaviors and binge eating. Given the cross-sectional design of the present study, an important 
future direction will be to test whether reward learning prospectively predicts symptom 
maintenance in BN. Moreover, an interesting future direction might be to assess the associations 
among reward-learning profiles and response to treatment in women with BN, given that reward-
learning profiles predicted treatment response and symptom maintenance after eight weeks in 
persons with major depressive disorder (Vrieze et al., 2013). 
Empirical Test of Volkow’s Model in Bulimia Nervosa 
 
45 
 
 The second aim of the present study was to empirically test Volkow’s model in women 
with BN. Results partially supported Volkow’s model in women with BN. First, preference for 
smaller-sooner amounts of money – but not food –was associated with decreased inhibitory 
control toward both disease-specific (food) and general (pleasant animal) images. Second, 
preference for smaller-sooner amounts of food – but not money – was associated with increased 
effort valuation (breakpoint) for food commodities. Third, preference for larger-later food – but 
not monetary – commodities were associated with increased ability to learn stimulus-response 
associations (reward learning). Associations of inhibitory control with effort valuation, and 
reward learning with inhibitory control, were not significant.  
Application of Volkow’s model in women with BN suggested that delay discounting may 
be particularly important for understanding the neurocognitive underpinnings of BN. For 
example, greater general (money) delay discounting was associated with decreased general 
(“pleasant” animal) and specific (food) inhibitory control, and greater specific (food) delay 
discounting was associated with increased specific (food) effort valuation. On the other hand, 
decreased specific (food) delay discounting was associated with greater general (money) reward 
learning. Given the importance of delay discounting in BN, a revised version of Volkow’s model 
with delay discounting as a central process that influences other reward-based processes may be 
warranted. Clinically, findings suggested that it may be important to target delay discounting as a 
means to modulate other reward-based processes and affect symptom expression in BN. A recent 
proof-of-principle study demonstrated that a single session of active (vs. sham) transcranial 
direct current stimulation (tDCS) – a well-tolerated form of non-invasive brain stimulation – 
delivered bilaterally over the dorsolateral prefrontal cortex, significantly decreased temporal 
discounting, eating-disorder cognitions, and urges to binge eat for 24 hours following active 
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tDCS in persons with BN (Kekic et al., 2017). Kekic et al. (2017)’s findings suggested that tDCS 
may have therapeutic benefit targeting dysfunctional delay discounting in BN.  
Correlations Among Reward-Processing Components, Affect, and Bulimic Symptoms  
The third aim of the present study was to test correlations among reward-processing 
components, affect, and bulimic symptoms in women with BN. Results provided partial support 
for the hypothesis that affective and bulimic symptoms would be associated with reward-
processing dysfunction. Increased inhibitory control toward food stimuli was associated with 
increased frequency of excessive exercise episodes. Increased inhibitory control toward pleasant 
animal images was also associated with increased frequency of fasting episodes. Results 
suggested that excessive exercise episode frequency was related to food-specific inhibitory 
control whereas fasting frequency was related to general inhibitory control in BN. Furthermore, 
results of the present study suggest that compensatory behaviors frequently seen in BN were 
driven by increased (vs. decreased) inhibitory control, counter to the idea that compensatory 
behaviors in BN are associated with decreased inhibitory control (i.e., more impulsivity).  
In addition, decreased ability to learn stimulus-response associations (reward learning) in 
the first block of the Probabilistic Reward Learning Task was significantly associated with 
increased frequency of self-induced vomiting episodes. The finding that reduced ability to learn 
stimulus-response associations in the first block of the reward-learning task was associated with 
frequency of self-induced vomiting is consistent with results of Labouliere et al. (2016), who 
also found that reduced reward learning was associated with greater self-induced vomiting 
frequencies. Previous research suggested that decreased reward learning was associated with low 
positive affect (i.e., anhedonia) in persons with depression (Pizzagalli et al., 2005; Vrieze et al., 
2013). Previous ecological momentary assessment research demonstrated that positive affect 
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significantly increased following purging (including self-induced vomiting) episodes in persons 
with BN (Berner et al., 2017), and other research found that self-induced vomiting created 
feelings of euphoria in BN (Abraham & Joseph, 1986). Thus, self-induced vomiting may be used 
as a means to increase positive affect and “boost” mood in persons with BN. There were no other 
significant associations among bulimic symptoms and reward-based domains.  
 There were several significant associations among affect and other study constructs. 
Negative urgency – the tendency to act impulsively when distressed (Whiteside & Lynam, 2001) 
– was significantly associated with two reward-processing components. First, negative urgency 
and delay discounting of food commodities were significantly and positively associated. The 
association of negative urgency and impulsive choice fits with reinforcement (Bandura, 1974) 
and self-regulation (Muraven & Baumeister, 2000) theories. From a reinforcement theory 
perspective, results suggested that persons with BN make impulsive choices toward food when 
distressed and use food as a means to remove or reduce negative affect (i.e., negative 
reinforcement). From a self-regulation perspective, stress may deplete extreme cognitive control 
over eating (i.e., dietary restraint) seen in BN and result in impulsive choice toward food. 
Clinicians might consider encouraging clients with BN to incorporate alternative “mood 
boosting” activities for decreasing negative emotionality. For example, the addition of strategies 
to help increase positive affect, such as behavioral activation or scheduling pleasant activities, to 
CBT-E may be particularly helpful. Therapists might also assist clients with BN to engage in 
regular eating patterns to minimize risk of lapses in strict cognitive control over eating (i.e., 
fasting or strict dieting), which may reduce risk for binge eating. 
Second, negative urgency was negatively associated with reward learning, such that 
reward learning decreased as negative urgency increased. Prior research has demonstrated an 
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association between reduced reward learning and increased stress (Porcelli, Lewis, & Delgado, 
2012), and social stress in particular (Lincoln et al., 2019), which may explain the significant 
association between reward learning and stress in the present study, though more research is 
needed. Finally, decreased levels of positive affect were significantly associated with increased 
discounting of monetary values in women with BN, suggesting that reduced positive affect is 
associated with greater impulsivity toward smaller-sooner monetary choices. Taken together, 
results point to associations among positive and negative affective (particularly negative 
urgency) domains.  
Limitations 
There were certain limitations that may have impacted study findings. First, women with 
BN had significantly higher body mass indices than HC women. This limitation was important, 
because clinically significant body mass index classifications (i.e., overweight or obese) are 
associated with greater reward-processing dysfunction. Research indicates that people with BN 
are more likely to have overweight or obesity (Bulik, Marcus, Zerwas, Levine, & La Via, 2012) 
compared to people without BN. Thus, even if groups in the present study had been matched on 
weight status, generalizability of findings would have been limited, given that the average person 
with BN has overweight or obesity. To control for effects of group differences in body mass 
index on reward-based processes, body mass index was entered as a covariate in statistical 
analyses. However, it is important to note that controlling for body mass index did not change 
any study findings. Second, women with BN and HC women were not matched on menstrual 
cycle phase due to issues this would have created with recruitment. However, start and end dates 
of the most recent menstrual period, typical duration of menstrual periods, use of hormonal 
contraceptive methods, and reproductive stage (e.g., menopause) were collected, and there were 
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no group differences in use of hormonal contraceptive methods, reproductive stage, and 
presence/absence of menstrual periods between groups. Third, the present study was cross-
sectional and did not examine longitudinal associations among reward-based processes, eating-
disorder symptoms, and affect in women with BN, limiting ability to infer causal directions 
among reward-based processes and symptom expression in BN.  
Conclusions 
 Taken together, results from the present study provided mixed support for the utility of 
applying a transdiagnostic reward processing model to persons with BN. My findings suggested 
that a modified model that includes delay discounting as a core neurocognitive feature of BN 
may have greater validity than Volkow’s model. Moreover, although there are certain parallels 
among BN and substance/alcohol use disorders, results from the present study did not suggest 
that BN is best conceptualized as a substance use disorder. Indeed, there was a lack of 
differences in reward-based processes between groups; a preference for larger-later (vs. smaller-
sooner) rewards, which has been observed in those with high levels of trait anxiety (Steinglass et 
al., 2017); and decreased reward learning, which has been associated with course and outcome in 
major depressive disorder (Vrieze et al., 2013). Results suggest that BN may be better 
understood as an internalizing disorder, consistent with past behavioral research on eating 
disorders (Forbush et al., 2018; Forbush, Hagan, et al., 2017; Forbush et al., 2010; Forbush & 
Watson, 2013).  
Previous research suggested that treatments targeting negative affect in BN do not 
outperform traditional cognitive-behavioral treatments for BN (Chen et al., 2017; Wonderlich et 
al., 2014). One reason why there are not outcome differences in negative-affect-specific and 
traditional (eating-disorder focused) treatments for persons with BN could be that previous 
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studies have treated all persons with BN as if they had the same affective and neurocognitive 
profiles. Previous research has demonstrated evidence for BN subtypes based on high (vs. low) 
levels of negative affect [e.g., Stice et al. (2008)]; however, no study, to my knowledge, has 
subtyped persons with BN based on neurocognitive domains, such as reward learning or delay 
discounting. Future research is needed to test whether reward learning and delay discounting are 
associated with treatment response in persons with BN. If certain neurocognitive domains predict 
treatment outcomes, this information could be leveraged to match persons with BN to treatments 
based on their neurocognitive profiles. Thus, an important next step for the field of eating 
disorders and BN, in particular, will be to test whether personalized medicine approaches, that 
match persons with BN to specific treatments based on affective and neurocognitive profiles, 
improve treatment outcomes for the disorder.  
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Table 1  
Demographic Characteristics by Group 
Characteristic BN (n=20) HC (n=20)    
 Mean (SD) Mean (SD) t p Cohen’s d 
Age (years) 20.00 
(2.36) 
20.40 
(2.93) 
-0.479 0.635 0.150 
Body mass index (BMI) 27.72 
(7.98) 
23.40 
(4.27) 
2.137 0.039 0.675 
    
2 
 
p 
Fisher’s Exact Test 
p 
Ethnicity and Race   3.034 0.695 - 
   Caucasian 14 15    
   African American 0 1    
   Asian 2 1    
   Native-American/Alaskan 
Native 
1 0    
   Multi-racial 2 1    
   Other 1 2    
Hispanic/Latinx 4 1 2.057 0.151 0.171 
Education   1.667 0.797 - 
   Some College 17 14    
   Associate’s Degree 1 1    
   Bachelor’s Degree 1 2    
   Master’s Degree 1 3    
Employment   1.026 0.311 0.501 
   Yes 12 15    
   No 8 5    
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Table 2 
 
Clinical Characteristics by Group 
Clinical Characteristic BN (n=20) HC (n=20)    
 Mean (SD) Mean (SD)    
Eating-Disorder Symptoms      
   Objective Binge Eating  
      Episodes 
26.10 (27.97) -    
   Restricting Episodes 21.35 (23.81) -    
   Compensatory/Excessive  
      Exercise Episodes 
24.45 (23.09) -    
   Self-Induced Vomiting     
      Episodes 
6.10 (16.25) -    
   Diuretic and/or Laxative 
      Misuse Episodes 
4.70 (13.46) -    
  
n (%) 
  
2 
 
p 
Fisher’s Exact 
Test p 
Treatment-Seeking: 
Psychotherapy 
  - - - 
   Yes 4 (20%) -    
   No 16 (80%) -    
Treatment-Seeking: 
Medications 
  - - - 
   Yes 0 -    
   No 20 -    
Current DSM-5 Disorders   - - - 
   Major Depressive Disorder 8 (40%) -    
   Generalized Anxiety  
      Disorder 
4 (20%) -    
   Panic Disorder 3 (15%) -    
   Post-Traumatic Stress  
      Disorder 
2 (10%) 
 
-    
   Social Anxiety Disorder  
      (Social Phobia) 
5 (25%) -    
Current Menstrual Periods   2.057 .151 .171 
   Yes 16 19    
   No 4 1    
Hormonal Contraceptive Use   2.506 .113 0.205 
   Yes 13 8    
   No   7 12    
Cigarette/Nicotine Use   - - - 
   Yes 0 0    
   No 20 20    
Note. Eating-disorder symptom frequencies (derived from the Eating Disorder Diagnostic 
Interview) were assessed over the past three months, in line with DSM-5 diagnostic criteria for 
BN. 
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Table 3 
 
Self-Report Measures by Group 
 BN (n=20) HC (n=20)    
Self-Report Measure Mean (SD) Mean (SD) t p Cohen’s d 
EPSI      
   Binge Eating 21.25 (6.59) 5.80 (4.90) 8.408 0.000 2.661 
   Excessive Exercise 9.00 (5.73) 3.70 (4.39) 3.283 0.001 1.038 
   Purging 2.90 (3.24) 0.55 (2.23) 2.668 0.006 0.850 
   Restricting 7.70 (7.13) 2.30 (2.51) 3.191 0.002 1.010 
ESI-bf      
   Substance Abuse Factor 17.70 (11.39) 11.90 (8.48) 1.826 0.038 0.578 
IDAS-II      
   General Depression 57.10 (11.19) 30.55 (6.97) 9.008 0.000 2.848 
   Dysphoria 32.05 (7.18) 15.05 (4.37) 9.040 0.000 2.680 
   Lassitude 18.60 (5.22) 10.05 (3.38) 6.145 0.000 1.944 
   Insomnia 16.85 (5.24) 10.80 (3.16) 4.421 0.000 1.398 
   Appetite Loss 7.75 (3.24) 4.45 (1.50) 4.129 0.000 1.307 
   Appetite Gain 11.15 (2.87) 5.25 (2.55) 6.870 0.000 2.173 
   Well-Being 16.75 (5.11) 24.00 (4.86) -4.600 0.000 -1.454 
   Ill Temper 9.00 (3.20) 5.95 (1.43) 3.895 0.000 1.231 
   Mania 11.50 (4.74) 7.85 (2.25) 3.110 0.002 0.984 
   Euphoria 8.75 (3.85) 7.90 (2.95) 0.783 0.219 0.248 
   Panic 18.45 (7.24) 8.95 (1.36) 5.771 0.000 1.824 
   Social Anxiety 16.95 (6.26) 8.45 (3.59) 5.226 0.000 1.666 
   Claustrophobia 8.90 (4.45) 5.35 (1.57) 3.367 0.002 1.064 
   Traumatic Intrusions 9.95 (4.35) 5.55 (2.33) 3.991 0.000 1.261 
   Traumatic Avoidance 10.50 (4.10) 6.50 (2.54) 3.709 0.001 1.173 
   Checking 9.10 (3.37) 4.80 (2.12) 4.831 0.000 0.871 
   Ordering 10.65 (5.33) 7.40 (3.00) 2.375 0.012 0.751 
   Cleaning 11.85 (7.43) 8.25 (1.77) 2.108 0.023 0.667 
PANAS      
   Positive Affect 21.30 (5.82) 28.60 (1.52) -3.646 0.000 -1.716 
   Negative Affect 21.95 (7.52) 11.45 (1.82) 6.608 0.000 1.919 
UPPS-P      
   Negative Urgency 2.77 (0.57) 1.81 (0.47) 5.829 0.000 1.838 
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Table 4 
 
Reward Processing and Inhibitory Control Measures by Group 
 BN HC    
 Mean (SD) Mean (SD) Test p Effect Size 
Inhibitory 
Control 
  F(2, 34) = 1.294 0.287  
   Animal  
   Commission  
   Errors 
16.833 (13.725) 11.150 (6.612) F(1, 35) = 2.603 0.116 0.528 
   Food  
   Commission  
   Errors 
17.833 (14.122) 13.050 (8.108) F(1, 35) = 2.396 0.131 0.415 
Delay 
Discounting 
  F(2, 33) = 5.893 0.006  
   MCQ k-valuea -5.617 (1.326) -4.533 (1.194) F(1, 34) = 9.367 0.004 0.859 
   FCQ k-valuea -4.544 (1.468) -3.364 (1.492)  F(1, 34) = 6.799 0.013 0.797 
Reward Learning   F(2, 20) = 3.620 0.046  
   Response Bias:  
      Block 1 
0.055 (0.145) 0.131 (0.115)  0.043 0.581 
   Response Bias:  
      Block 2 
0.128 (0.204) 0.161 (0.236)  0.263 0.150 
   Response Bias:  
      Block 3 
0.175 (0.145) 0.108 (0.169)  0.115 0.425 
   Reward  
   Learning 
0.120 (0.166) -0.023 (0.165) F(1, 21) = 6.856 0.016 0.864 
Effort Valuation      
   Breakpoint 16.4722 (5.791) 12.675 (7.270) U=130, Z=-1.605 0.149 -0.261 
   Intensity 19.72 (24.571) 20.75 (35.139) U=118, Z=-1.821 0.072 -0.295 
   Omax 30.889 (20.230) 18.225 (12.046) U=92.5, Z=-2.579 0.009 -0.418 
   Pmax 10.111 (7.586) 9.625 (6.836) U=176, Z=-0.119 0.919 -0.019 
   Elasticity   F(1, 642)=1.097 0.295  
ak-values presented were natural-logarithm-transformed. 
  
 
74 
 
Table 5 
 
Empirical Test of Volkow’s Model in Women with Bulimia Nervosa 
 Inhibitory Control Delay 
Discounting 
  
 Animal Food Money Food Reward 
Learning 
Effort 
Valuation 
(Breakpoint) 
Inhibitory Control       
   Animal -      
   Food  .920** -     
Delay Discounting       
   Money .513* .437* -    
   Food .245 .131 .393* -   
Reward Learning .141 .123 -.256 -.550* -  
Effort Valuation 
(Breakpoint) 
.118 .104 -.130 .607** -.064 - 
Note. Correlations are non-parametric Spearman’s rho (rs) values. 
 
*p < 0.05 (one-tailed) 
**p<0.01 (one-tailed) 
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Figure 1. Volkow’s Model of Imbalanced Reward-Processing and Inhibitory Control 
Systems. Note that this model posits that three distinct facets of reward processing override 
inhibitory control over reward-driven behaviors (e.g., binge eating) and maintain behaviors. 
First, increased wanting (delay discounting) of a substance (e.g., alcohol, food) may decrease 
inhibitory control over substance use, resulting in over-consumption accompanied by loss-of-
control (e.g., binge eating). Next, repetitive use of a substance, despite negative consequences 
(e.g., weight gain, psychosocial impairment), suggests that learning alternative stimulus-reward 
associations (reward learning) may be challenging. Impaired reward learning may override 
inhibitory control and facilitate disinhibition. Decreased inhibitory control, in turn, increases 
efforts (effort valuation) to obtain substances. Finally, reward learning and delay discounting 
may mutually reinforce and strengthen one another. 
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Figure 2. Group Differences in Response Bias by Block on the Probabilistic Reward 
Learning Task. BN=women with bulimia nervosa; HC=healthy control women. 
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Figure 3. Demand Curves by Group for the Food-Specific Hypothetical Purchase Task. 
BN=women with bulimia nervosa; HC=healthy control women. 
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Figure 4. Empirical Test of Volkow’s Model of Imbalanced Reward-Processing and 
Inhibitory Control Systems in Women with Bulimia Nervosa. Correlations are non-parametric 
Spearman’s rho (rs) values. DD-F=delay discounting of food commodities (k-values); DD-
M=delay discounting of monetary commodities (k-values); EV=Effort Valuation (breakpoint on 
food-specific hypothetical purchase task); IC-A=commission errors toward animal images on 
go/no-go task (inhibitory control); IC-F=commission errors toward food images on go/no-go task 
(inhibitory control); RL=Reward Learning derived from Probabilistic Reward Learning Task.  
*p < 0.05 (one-tailed) 
**p<0.01 (one-tailed) 
